Seno Medical’s Photoacoustic Imaging Modality Added to DICOM® Standards Update
Seno’s Imagio® System Uses Photoacoustic (Opto-acoustic) and Ultrasound Imaging to help doctors better characterize suspicious breast lesions to avoid unnecessary invasive biopsies and improve patient care. [San Antonio, TX – July 20, 2023] Seno Medical’s technology platform for the Imagio® Breast Imaging System – which includes Photoacoustic imaging – has been added to the Digital Imaging and Communications […]
Seno Medical’s SenoGram® Decision Support Tool Named Winner in 2023 Artificial Intelligence Excellence Awards
[SAN ANTONIO, TX – March 23, 2023] The Artificial Intelligence Excellence Awards program has selected Seno Medical’s AI platform, SenoGram® — exclusively available in conjunction with the company’s Imagio® Breast Imaging System — as a winner in its first annual program. SenoGram® is an artificial intelligence (AI) decision-support tool that helps physicians interpret new images from the Imagio® System. The SenoGram®, […]
Seno Medical Inks Exclusive Agreement with Genetik, Inc. as Distributor for Imagio® Breast Imaging System in Southeast Asia
(SAN ANTONIO, TX – January 13, 2023) Seno Medical has entered into an exclusive distributor agreement with Genetik, Inc., to market, sell and service the company’s groundbreaking Imagio® Opto-Acoustic/Ultrasound (OA/US) Breast Imaging System. This distributor agreement – a first for Seno – will enable Genetik to regionally distribute the Imagio® System in Singapore, where the distributor is […]
Retrospective Study of Seno Medical’s Imagio® Breast Imaging System Published in American Journal of Roentgenology Shows System May Help Reduce Biopsies of Benign Breast Masses Compared to Ultrasound Alone
Study found OA/US fused imaging significantly improved specificity at fixed sensitivity compared to conventional ultrasound [SAN ANTONIO, TX – January 5, 2023] A retrospective study of Seno Medical‘s Imagio® Breast Imaging System published in the American Journal of Roentgenology found that the company’s opto-acoustic/ultrasound (OA/US) technology significantly improves specificity at fixed sensitivity compared to conventional ultrasound. The study, Optoacoustic […]
Poster Presentation at RSNA Compares Seno Medical’s OA/US Breast Imaging with AI Decision Support to Ultrasound Alone; Finds Significantly Better Specificity to Support Clinical Decision Making Conf
[SAN ANTONIO, TX – December 1, 2021] A study presented at the Radiological Society of North America (RSNA)’s annual meeting showed Texas-based Seno Medical Instruments, Inc. (Seno)’s Imagio® opto-acoustic ultrasound (OA/US) breast imaging provides significantly better specificity than ultrasound alone. The poster, “Performance of Optoacoustic Ultrasound with an Artificial Intelligence-based Decision Support Tool vs Ultrasound Alone to Classify […]
Seno Medical’s Market-Ready Imagio® OA/US Breast Imaging System Launches at RSNA 2022, Booth 6120
The category defining Imagio® Breast Imaging System helps physicians differentiate between benign and malignant breast lesions using a novel combination of ultrasound and opto-acoustic technology. [SAN ANTONIO, TX – November 27, 2022] Seno Medical, makers of the Imagio® Breast Imaging System – a revolutionary new modality in breast imaging – will officially launch the commercially available system at […]
Seno Medical Launches Its Scans Across America Bus Tour for Hands-on Demonstrations of the Imagio® Breast Imaging System
(SAN ANTONIO, TX – August 9, 2022) Seno Medical will bring its category-defining Imagio® Breast Imaging System to the doorsteps of clinicians and healthcare providers throughout the US with the launch of its Scans Across America hands-on experience tour starting in August (www.experienceimagio.com/tour/). Recently honored with a Gold Edison Award as well as a Gold Medical […]
Seno Medical’s Market-Ready Imagio® OA/US Breast Imaging System Receives Supplemental FDA PMA Approval
The category-defining Imagio® Breast Imaging System helps physicians differentiate between benign and malignant breast lesions using a novel combination of ultrasound and opto-acoustic technology. [SAN ANTONIO, TX – June 28, 2022] Seno Medical’s Imagio® Breast Imaging System, a revolutionary new modality in breast imaging, has received supplemental premarket approval (PMA) from the Center for Devices and Radiological Health […]
Edison Awards Program Honors Seno Medical’s Imagio® Breast Imaging System With a “Best of the Best” GOLD Award
[SAN ANTONIO, TX – April 25, 2022] Seno Medical’s Imagio ® Breast Imaging System has been selected by the Edison Awards program as a GOLD award winner in the Science & Medical category. The award was presented at the program’s annual gala on April 21, 2022. The Edison Award’s Gold, Silver and Bronze Winners are chosen as […]
Seno Medical’s Imagio® Breast Imaging System Selected As GOLD Winner in Medical Device Excellence Awards
[SAN ANTONIO, TX – April 8, 2022] The 2022 Medical Device Excellence Awards program has selected Seno Medical’s Imagio® Breast Imaging System as a GOLD award winner in the Radiological, Imaging, and Electromechanical Devices category. The Medical Design Excellence Awards (MDEA) is the premier awards program for the medtech industry. Since its inception in 1998, the […]